Zobrazeno 1 - 5
of 5
pro vyhledávání: '"José A Meade-Aguilar"'
Autor:
Farah Tamirou, Frederic Houssiau, Ali Duarte-García, Maria Dall’Era, Brad H Rovin, Larry J Prokop, Gabriel Figueroa-Parra, Cynthia S Crowson, Michael S Putman, Fernando C Fervenza, Alain Sanchez-Rodriguez, María C Cuéllar-Gutiérrez, Mariana González-Treviño, Jaime Flores-Gouyonnet, José A Meade-Aguilar, M Hassan Murad
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/a3eee3392158483083aac4b060fe6fad
Autor:
José A Meade-Aguilar, Yessica N Varela-Martinez, Sandra P Ramirez-Eguía, Edgar Sanchez-Hurtado, Tania O Mondragón-Labelle, Gabriela A Bautista-Aguilar, Ernesto Deloya-Tomas, Marian E Phinder-Puente, Orlando R Pérez Nieto
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
The coronavirus disease 2019 has been demonstrated to be a trigger for multiple immune-mediated diseases, such as antineutrophil cytoplasmic antibody-associated vasculitis. Associated vasculitis consists of rare autoimmune disorders that predominantl
Externí odkaz:
https://doaj.org/article/57aa07b8f3f442218e84d009f1f8dcf4
Publikováno v:
Critical Care. 27
Publikováno v:
Clinical Rheumatology. 41:2809-2816
Rituximab is a first-line therapy in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Among previous studies evaluating its efficacy, the Hispanic/Latino population has been underrepresented. This study aimed to
Autor:
Orlando R. Pérez-Nieto, Rafael A. Reyes-Monge, Ignacio Rodríguez-Guevara, Eder I. Zamarrón-López, José A. Meade-Aguilar
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/69b717158950434b84df51f9fb1091c6